Search Within

David Hyman

  1. "Radiology, Department of"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (46)
  2. Early Drug Development Service (46)
  3. Radiology, Department of (46)
  4. Solid Tumor Oncology Division (46)
  5. GSK Faculty (35)
  6. Department of Pathology and Laboratory Medicine (30)

More Groups

People
  1. Gary Ulaner (22)
  2. David Solit (16)
  3. Eli Diamond (15)
  4. Alexander Drilon (13)
  5. Omar Abdel-Wahab (13)
  6. Michael Berger (12)

More People

Years
  1. 2021 (1)
  2. 2020 (6)
  3. 2019 (10)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. JCO Precision Oncology (5)
  3. Cancer Discovery (4)
  4. Blood (3)
  5. Clinical Cancer Research (3)
  6. Pediatric Blood and Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (8)
  3. Lippincott Williams & Wilkins (4)
  4. American Society of Hematology (3)
  5. Nature Publishing Group (3)
  6. Springer (3)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • (89)Zr-trastuzumab PET/CT for detection of human epidermal growth factor receptor 2-positive metastases in patients with human epidermal growth factor receptor 2-negative primary breast cancer
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Lyashchenko, S. K.; Lewis, J. S.; Carrasquillo, J. A.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent Cobimetinib for adults with histiocytic disorders: Interim results
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • AKT inhibition in solid tumors with AKT1 mutations
    Journal Article

    Hyman, D. M.; Smyth, L. M.; Donoghue, M. T. A.; Westin, S. N.; Bedard, P. L.; Dean, E. J.; Bando, H.; El-Khoueiry, A. B.; PeĢrez-Fidalgo, J. A.; Mita, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Meeting Abstract

    Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Ross, D. S.; Corben, A.; Chandarlapaty, S.; Goldfarb, S.; McArthur, H.; Erinjeri, J. P.; Solomon, S. B.; Kolb, H.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Hatzoglou, V.; Patel, S.; Abdel-Wahab, O.; Rampal, R.; Hyman, D. M.; Holodny, A. I.; Raj, A.
    Orphanet Journal of Rare Diseases (2016)

    Fulltext@MSK | Save
  • Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay
    Meeting Abstract

    Abida, W.; Brennan, R.; Armenia, J.; Curtis, K. R.; Gopalan, A.; Arcila, M. E.; Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Diffuse loss of cerebral grey matter structures in Erdheim-Chester disease
    Meeting Abstract

    Diamond, E. L.; Hatzoglou, V.; Pandya, S.; Abdel-Wahab, O.; Hyman, D. M.; Rampal, R.; Raj, A.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save